Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision label on the study page was updated from v3.5.3 to v3.5.4. This represents a minor update to the record and does not modify the trial details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-18T13:30:07.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s footer/version label was updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a minor site release change rather than a content change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-26T15:37:03.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T13:59:54.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0; the previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T16:48:30.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T19:19:30.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    The page shows a minor revision update (Revision: v3.4.2 added; Revision: v3.4.1 removed) and no changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:21:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.